These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16954103)
21. Topical phenytoin nanostructured lipid carriers: design and development. Motawea A; Borg T; Abd El-Gawad AEH Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451 [TBL] [Abstract][Full Text] [Related]
22. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement. Mandpe L; Pokharkar V Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553 [TBL] [Abstract][Full Text] [Related]
23. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388 [TBL] [Abstract][Full Text] [Related]
24. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Shete H; Patravale V Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345 [TBL] [Abstract][Full Text] [Related]
25. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Mendes IT; Ruela ALM; Carvalho FC; Freitas JTJ; Bonfilio R; Pereira GR Colloids Surf B Biointerfaces; 2019 May; 177():274-281. PubMed ID: 30763792 [TBL] [Abstract][Full Text] [Related]
26. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
27. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation. Khurana S; Jain NK; Bedi PM Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872 [TBL] [Abstract][Full Text] [Related]
28. Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat. Rajendrakumar K; Madhusudan S; Pralhad T Eur J Pharm Biopharm; 2005 May; 60(1):39-46. PubMed ID: 15848054 [TBL] [Abstract][Full Text] [Related]
29. Fabrication of Nanostructured Lipid Carriers (NLC)-Based Gels from Microemulsion Template for Delivery Through Skin. Joshi MD; Prabhu RH; Patravale VB Methods Mol Biol; 2019; 2000():279-292. PubMed ID: 31148022 [TBL] [Abstract][Full Text] [Related]
31. Amphiphilic NLC-Gel formulation loaded with Sebacoyl dinalbuphine ester and Nalbuphine for localized postoperative pain management. Lin CL; Li YL; Chen YW; Kuo CH; Tu TY; Liu YF; Tsai JC; Shyong YJ Int J Pharm; 2024 Jun; 659():124295. PubMed ID: 38823469 [TBL] [Abstract][Full Text] [Related]
32. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Sathe P; Saka R; Kommineni N; Raza K; Khan W Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674 [TBL] [Abstract][Full Text] [Related]
33. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin. Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487 [TBL] [Abstract][Full Text] [Related]
34. Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis. Keshri L; Pathak K Pharm Dev Technol; 2013; 18(3):634-44. PubMed ID: 22339250 [TBL] [Abstract][Full Text] [Related]
35. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
36. Nanostructured Lipid Carriers (NLC) as Vehicles for Topical Administration of Sesamol: In Vitro Percutaneous Absorption Study and Evaluation of Antioxidant Activity. Puglia C; Lauro MR; Offerta A; Crascì L; Micicchè L; Panico AM; Bonina F; Puglisi G Planta Med; 2017 Mar; 83(5):398-404. PubMed ID: 27124246 [TBL] [Abstract][Full Text] [Related]
37. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Cirri M; Bragagni M; Mennini N; Mura P Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833 [TBL] [Abstract][Full Text] [Related]
38. Nanostructured Lipid Carrier-Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases. Garg NK; Tandel N; Bhadada SK; Tyagi RK Front Pharmacol; 2021; 12():713616. PubMed ID: 34616297 [TBL] [Abstract][Full Text] [Related]
39. Podophyllotoxin-Loaded Nanostructured Lipid Carriers for Skin Targeting: In Vitro and In Vivo Studies. Zhao J; Piao X; Shi X; Si A; Zhang Y; Feng N Molecules; 2016 Nov; 21(11):. PubMed ID: 27869698 [TBL] [Abstract][Full Text] [Related]
40. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery. Shrivastava N; Khan S; Baboota S; Ali J Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]